Maxwell P R, Rink E, Kumar D, Mendall M A
Department of General Practice and Primary Care, St George's Hospital Medical School, London, United Kingdom.
Am J Gastroenterol. 2002 Jan;97(1):104-8. doi: 10.1111/j.1572-0241.2002.05428.x.
Data suggest that subjects with irritable bowel syndrome are more likely to report a recent course of antibiotics. This study tests the hypothesis that a course of antibiotics is a risk factor for an increase in the number of functional bowel complaints over a 4-month period in a general population sample.
We initiated a prospective case-control study in three general practices in South London. Consecutive patients aged 16-49 attending their general practitioner with non-GI complaints and given a prescription for antibiotics were invited to participate. Comparison subjects who had not had antibiotics for 1 yr were identified from the practice records by age group, gender, and previous general practitioner visits. Fifty-eight antibiotic and 65 control patients agreed to participate. Questionnaires covering demographic, GI, and psychological data were sent at recruitment and at 4 months. Seventy-four percent of subjects completed the study. The number of symptoms at follow-up compared to that at recruitment.
Twenty of 42 antibiotic subjects (48%) versus 11/49 control subjects (22%) demonstrated one or more additional functional bowel symptoms at 4 months (unadjusted odds ratio = 3.14 [1.27-7.75]) (chi2 = 6.4, p = 0.01). Ten of 42 antibiotic subjects (24%) versus 3/49 control subjects (6%) demonstrated two or more additional functional bowel symptoms at 4 months (unadjusted odds ratio = 4.79 [1.22-18.80]) (chi2 = 5.8, p = 0.02).
Functional bowel symptoms come and go, but subjects who are given a course of antibiotics are more than three times as likely to report more bowel symptoms 4 months later than controls.
数据表明,肠易激综合征患者更有可能报告近期使用过抗生素疗程。本研究检验了这样一个假设:在普通人群样本中,抗生素疗程是4个月内功能性肠道不适数量增加的一个风险因素。
我们在伦敦南部的三个全科诊所开展了一项前瞻性病例对照研究。邀请连续16 - 49岁因非胃肠道疾病就诊于全科医生并开具抗生素处方的患者参与。通过年龄组、性别和之前的全科医生就诊记录,从诊所记录中识别出过去1年未使用过抗生素的对照受试者。58名使用抗生素的患者和65名对照患者同意参与。在招募时和4个月时发送涵盖人口统计学、胃肠道和心理数据的问卷。74%的受试者完成了研究。将随访时的症状数量与招募时的症状数量进行比较。
42名使用抗生素的受试者中有20名(48%)在4个月时出现了一种或多种额外的功能性肠道症状,而49名对照受试者中有11名(22%)出现了这种情况(未调整优势比 = 3.14 [1.27 - 7.75])(χ² = 6.4,p = 0.01)。42名使用抗生素的受试者中有10名(24%)在4个月时出现了两种或更多额外的功能性肠道症状,而49名对照受试者中有3名(6%)出现了这种情况(未调整优势比 = 4.79 [1.22 - 18.80])(χ² = 5.8,p = 0.02)。
功能性肠道症状时有时无,但接受抗生素疗程的受试者在4个月后报告肠道症状增多的可能性是对照组的三倍多。